Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Psychopharmacology

• Publication date

  2010-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-010-1834-7PMID 20358363PMCID PMC2869248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynorphin, stress, and depression.

  2010influential reference
• Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase (PKA) within the medial prefrontal cortex of rats

  2009cited by this paper
• Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.

  2009cited by this paper
• Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats

  2009cited by this paper
• Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor.

  2009cited by this paper
• Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

  2008cited by this paper
• Dopamine and reward: The anhedonia hypothesis 30 years on

  2008cited by this paper
• The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward.

  2008cited by this paper
• Massively parallel screening of the receptorome.

  2008cited by this paper
• Anxiolytic-Like Effects of κ-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats

  2007cited by this paper
• The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.

  2007cited by this paper
• Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats

  2007cited by this paper
• Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats.

  2007influential reference
• Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

  2006cited by this paper
• Pattern of use and subjective effects of Salvia divinorum among recreational users.

  2006cited by this paper
• A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity.

  2006cited by this paper
• Salvinorin A: from natural product to human therapeutics.

  2006cited by this paper
• Prior Activation of Kappa Opioid Receptors by U50,488 Mimics Repeated Forced Swim Stress to Potentiate Cocaine Place Preference Conditioning

  2006cited by this paper
• Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats.

  2006cited by this paper
• PCP: from pharmacology to modelling schizophrenia.

  2005cited by this paper
• Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

  2005cited by this paper
• Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors

  2005cited by this paper
• Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

  2005cited by this paper
• The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers

  2005cited by this paper
• Stress and depression.

  2005cited by this paper
• Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats

  2004cited by this paper
• Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional Considerations

  2004cited by this paper
• The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward

  2004cited by this paper
• Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.

  2004cited by this paper
• Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.

  2003cited by this paper
• NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

  2003cited by this paper
• Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats

  2003cited by this paper
• Cocaine disrupts both behavioural inhibition and conditional discrimination in rats

  2003cited by this paper
• Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

  2002cited by this paper
• The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

  2002cited by this paper
• Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  2002cited by this paper
• Sustained attention deficit in bipolar disorder.

  2002cited by this paper
• Mouse and Rat Anesthesia and Analgesia

  2001cited by this paper
• Effects of Ketamine in Normal and Schizophrenic Volunteers

  2001cited by this paper
• Antidepressant effects of the herb Salvia divinorum: a case report.

  2001cited by this paper
• Impaired attention as an endophenotype for molecular genetic studies of schizophrenia.

  2001cited by this paper
• Sustained attention deficits as markers of genetic susceptibility to schizophrenia.

  2000cited by this paper
• Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens.

  1999cited by this paper
• The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

  1999cited by this paper
• Up-regulation of [3H]DTG but not [3H](+)-pentazocine labeled sigma sites in mouse spinal cord by chronic morphine treatment.

  1998cited by this paper
• kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.

  1996cited by this paper
• The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity

  1995cited by this paper
• U50,488, a κ opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

  1994cited by this paper
• Salvia divinorum and salvinorin A: new pharmacologic findings.

  1994cited by this paper
• Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.

  1994cited by this paper
• Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons.

  1992cited by this paper
• The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.

  1992cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

  1990cited by this paper
• Psychotomimesis mediated by kappa opiate receptors

  1986cited by this paper
• Ketamine-induced locomotion in rats in an open-field.

  1985cited by this paper
• Attenuation of amphetamine‐induced motor stimulation and stereotypy by 6‐hydroxydopamine in the rat

  1973cited by this paper
• A continuous performance test of brain damage.

  1956cited by this paper

• The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies

  2025cites this paper
• Bifunctional modulation of NMDA and opioid receptors in ketamine reinforcement and misuse: implications for substance use disorder treatment.

  2025cites this paper
• Is poor dose selection undermining the translational validity of antidepressant research involving animal models?

  2025cites this paper
• The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors

  2025cites this paper
• Kappa opioid receptor mediated operant performance in male and female rats.

  2024cites this paper
• Ketamine and hydroxynorketamine as novel pharmacotherapies for the treatment of Opioid-Use Disorders.

  2024cites this paper
• The N-methyl-d-aspartate receptor hypothesis of ketamine’s antidepressant action: evidence and controversies

  2024cites this paper
• Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine.

  2023cites this paper
• Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine

  2023cites this paper
• Sex-Dependent Attentional Impairments in a Subchronic Ketamine Mouse Model for Schizophrenia

  2023cites this paper
• Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?

  2023cites this paper
• Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors

  2022cites this paper
• Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability.

  2022cites this paper
• Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders

  2022cites this paper
• Targeting Affective Mood Disorders With Ketamine to Prevent Chronic Postsurgical Pain

  2022cites this paper
• The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies

  2022cites this paper
• Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats

  2022cites this paper
• Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.

  2021cites this paper
• Mechanisms of Ketamine and its Metabolites as Antidepressants.

  2021cites this paper
• Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects.

  2021cites this paper
• Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition

  2021cites this paper
• Biologically active compounds from Lamiaceae family: Central nervous system effects

  2021cites this paper
• Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability

  2021cites this paper
• In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.

  2021cites this paper
• Profile of a short-acting κ-antagonist, LY2795050, on self-grooming behaviors, forced swim test and locomotor activity: sex comparison in mice

  2021cites this paper
• Concordant neurophysiological signatures of cognitive control in humans and rats

  2021cites this paper
• In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy

  2021cites this paper
• Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects

  2021cites this paper
• Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders.

  2020cites this paper
• The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach.

  2020cites this paper
• Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates

  2020cites this paper
• Sex-related differences in intravenous ketamine effects on dissociative stereotypy and antinociception in male and female rats.

  2020cites this paper
• Frontal Cortical Monoamine Release, Attention, and Working Memory in a Perinatal Nicotine Exposure Mouse Model Following Kappa Opioid Receptor Antagonism.

  2020cites this paper
• The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors Are Associated with Interleukin-6

  2020cites this paper
• The Neuropharmacology of Impulsive Behaviour, an Update.

  2020cites this paper
• Pathway-Phenotypes of Non-responders and Partial Responders to Treatment With Antipsychotics in Schizophrenia: A Machine Learning Study

  2020cites this paper
• Impact of Ketamine on Pain Management in Cesarean Section: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Opioid system modulation of cognitive affective bias: implications for the treatment of mood disorders

  2020cites this paper
• Neonatal 6-OHDA Lesion Model in Mouse Induces Cognitive Dysfunctions of Attention-Deficit/Hyperactivity Disorder (ADHD) During Young Age

  2020cites this paper
• Novel Targets to Treat Depression: Opioid-Based Therapeutics.

  2020cites this paper
• The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.

  2019cites this paper
• Targeting opioid dysregulation in depression for the development of novel therapeutics.

  2019cites this paper
• Naloxone reversed cognitive impairments induced by repeated morphine under heavy perceptual load in the 5‐choice serial reaction time task

  2019cites this paper
• Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology?

  2019cites this paper
• Association of Craving and Depressive Symptoms in Ketamine-Dependent Patients Undergoing Withdrawal Treatment.

  2019cites this paper
• Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data?

  2019cites this paper
• κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition

  2018cites this paper
• NMDA Receptor Independent, Astrocytic Antidepressant Actions of Ketamine

  2018cites this paper
• General anesthetics effects in behavioral modulation: the particular case of ketamine

  2018cites this paper
• Opioid modulation of cognitive impairment in depression.

  2018cites this paper
• Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

  2018cites this paper
• Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

  2018cites this paper
• Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats.

  2017cites this paper
• A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.

  2017cites this paper
• In Vitro Effects of Salvinorina on mRNA Expression of Liver

  2017cites this paper
• The Kappa Opioid Agonist , Salvinorin A , Attenuates Locomotor Effects of Morphine but not Morphine-Induced Conditioned Place Preference

  2017cites this paper
• Pituitary adenylate cyclase-activating polypeptide (PACAP) disrupts motivation, social interaction, and attention in male Sprague-Dawley rats

  2016cites this paper
• Exposure to Ketamine Anesthesia Affects Rat Impulsive Behavior

  2016cites this paper
• The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Neurobiology of Stress-Related Behaviors

  2016cites this paper
• Does the Clinical Benefit of Ketamine Treatment Offer Any Clues to Autism Spectrum Disorder Etiology?

  2016cites this paper
• Ketamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies

  2016cites this paper
• Kappa Opioids, Salvinorin A and Major Depressive Disorder

  2016cites this paper
• The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation.

  2016cites this paper
• Pituitary Adenylate Cyclase–Activating Polypeptide Disrupts Motivation, Social Interaction, and Attention in Male Sprague Dawley Rats

  2016cites this paper
• Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release

  2016cites this paper
• Imaging the effects of ketamine use and abuse in the brain

  2015cites this paper
• The Uncompetitive N-methyl-D-Aspartate Antagonist Memantine Reduces Binge-Like Eating, Food-Seeking Behavior, and Compulsive Eating: Role of the Nucleus Accumbens Shell

  2015cites this paper
• Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

  2015cites this paper
• Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

  2015cites this paper
• The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats.

  2014cites this paper
• Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models

  2014cites this paper
• The 5-choice serial reaction time task: a task of attention and impulse control for rodents.

  2014cites this paper
• an Agonist PET Tracer for k-Opioid Receptors: A Study in Nonhuman Primates

  2013cites this paper
• Dissociable Effects of Kappa-Opioid Receptor Activation on Impulsive Phenotypes in Wistar Rats

  2013cites this paper
• Determination of In Vivo Bmax and Kd for 11C-GR103545, an Agonist PET Tracer for κ-Opioid Receptors: A Study in Nonhuman Primates

  2013influential citation
• Inhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task.

  2013influential citation
• Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug

  2013cites this paper
• 4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist.

  2013cites this paper
• Role of Kappa-Opioid Receptors in Stress-Induced Behaviors

  2013cites this paper
• Spinal Cord Injury-Induced Discharges Modify the Function of Glutamatergic System and Improve Ground and Skilled Locomotor Control

  2013cites this paper
• Development of κ opioid receptor antagonists.

  2013cites this paper
• The dynorphin/j-opioid receptor system and its role in psychiatric

  2012cites this paper
• Corticotropin-Releasing Factor (CRF)-Induced Disruption of Attention in Rats Is Blocked by the κ-Opioid Receptor Antagonist JDTic

  2012influential citation
• Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain.

  2012cites this paper
• The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats

  2012cites this paper
• The K appa Opioid Agonist, Salvinorin A, Att enuates Locomotor Effec ts of Morphine but not Morphine-Induced Conditioned Place Preference

  2012cites this paper
• The dynorphin/κ-opioid receptor system and its role in psychiatric disorders

  2011cites this paper
• Learning and Memory Impairment Induced by Salvinorin A, the Principal Ingredient of Salvia divinorum, in Wistar Rats

  2011cites this paper
• Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A

  2011influential citation
• Schizophrenia-Like Attentional Deficits Following Blockade of Prefrontal Cortex GABAA Receptors

  2011cites this paper
• Endogenous opiates and behavior: 2010.

  2011cites this paper
• Comparative effects of different test day challenges on performance in the 5-choice serial reaction time task.

  2011cites this paper
• Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A

  2011cites this paper
• Salvinorin A Produces Cerebrovasodilation through Activation of Nitric Oxide Synthase, &kgr; Receptor, and Adenosine Triphosphate–sensitive Potassium Channel

  2011cites this paper
• Investigating the Effects of Novel Kappa Opioid Receptor Agonists on the Dopamine Transporter

  2011cites this paper
• Pharmacological activity of Salvinorin A, the major component of Salvia divinorum

  2011cites this paper
• Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.

  2011cites this paper
• Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo

  2011cites this paper
• Neuroscience and Biobehavioral Reviews

  year unknowncites this paper